PMID: 42120723

Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial.

Aronne Louis J, Horn Deborah B, le Roux Carel W, Chao Ariana M, Ho Wayne, Halpern Bruno, Griffin Ryan, Xie Cathy, Valderas Elisa Gomez, Lee Clare J

Nature medicine · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.